{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:36Z","timestamp":1793831256161,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022801","name":"Hubei University of Technology Hubei Provincial Key Laboratory of Green Materials for Light Industry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019035","name":"Hubei Province Science and Technology Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114088","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T09:51:19Z","timestamp":1737366679000},"page":"114088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis"],"prefix":"10.1016","volume":"148","author":[{"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-2139","authenticated-orcid":false,"given":"Youzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2025.114088_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000521908","article-title":"Meta-Analysis of the Efficacy and Safety of Finerenone in Diabetic Kidney Disease","volume":"47","author":"Zheng","year":"2022","journal-title":"Kidney Blood Press. Res."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114088_b0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000504240","article-title":"A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease","volume":"49","author":"Hanna","year":"2020","journal-title":"Blood Purif."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13098-023-01130-w","article-title":"Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats","volume":"15","author":"Yang","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bph.15693","article-title":"Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K\/Akt\/mTOR signals","volume":"179","author":"Tang","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0025","first-page":"102","article-title":"Sarcopenia in diabetic nephropathy: a cross-sectional study","volume":"56","author":"Celiker","year":"2018","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114088_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917113","article-title":"Diabetic muscular atrophy: molecular mechanisms and promising therapies","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.intimp.2025.114088_b0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","article-title":"Frailty and sarcopenia - newly emerging and high impact complications of diabetes","volume":"31","author":"Sinclair","year":"2017","journal-title":"J. Diabetes Complications."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12967-023-04369-z","article-title":"Mitochondrial dysfunction: roles in skeletal muscle atrophy","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114088_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105807","article-title":"Skeletal muscle atrophy: from mechanisms to treatments","volume":"172","author":"Yin","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7610","key":"10.1016\/j.intimp.2025.114088_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","article-title":"The NLRP3 inflammasome and its role in sepsis development","volume":"43","author":"Danielski","year":"2020","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0065","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12153","article-title":"NLRP3 inflammasome in sepsis (Review)","volume":"24","author":"Shi","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0070","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jcsm.12662","article-title":"Amelioration of diabetes-induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein-7","volume":"12","author":"Aluganti Narasimhulu","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41420-021-00648-0","article-title":"Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3\/GSDMD pathway-mediated pyroptosis","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/thno.74831","article-title":"Ablation of NLRP3 inflammasome attenuates muscle atrophy via inhibiting pyroptosis, proteolysis and apoptosis following denervation","volume":"13","author":"You","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2025.114088_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-051013-110046","article-title":"The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus","volume":"66","author":"Vallon","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114088_b0095","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.13087","article-title":"Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO\u20111\/NLRP3 axis","volume":"28","author":"Zhang","year":"2023","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2025.114088_b0100","first-page":"384","article-title":"Dapagliflozin attenuates NLRP3\/caspase-1 signaling pathway-mediated pyroptosis of vascular smooth muscle cells by downregulating CTSB","volume":"29","author":"Li","year":"2023","journal-title":"Altern. Ther. Health Med."},{"issue":"17","key":"10.1016\/j.intimp.2025.114088_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.114088_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050753","article-title":"Dapagliflozin ameliorates cognitive impairment in aluminum-chloride-induced Alzheimer's disease via modulation of AMPK\/mTOR, oxidative stress and glucose metabolism","volume":"16","author":"Samman","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247234","article-title":"Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells","volume":"16","author":"Zaibi","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166912","article-title":"Dapagliflozin and metformin in combination ameliorates diabetic nephropathy by suppressing oxidative stress, inflammation, and apoptosis and activating autophagy in diabetic rats","volume":"1870","author":"Jaikumkao","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"Suppl 4","key":"10.1016\/j.intimp.2025.114088_b0125","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.intimp.2025.114088_b0130","doi-asserted-by":"crossref","unstructured":"Wang P, Lan Q, Huang Q, et al. Schisandrin A Attenuates Diabetic Nephropathy via EGFR\/AKT\/GSK3beta Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology (Basel). Aug 8 2024;13(8). doi:10.3390\/biology13080597.","DOI":"10.3390\/biology13080597"},{"key":"10.1016\/j.intimp.2025.114088_b0135","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2147\/DMSO.S221841","article-title":"AdipoRon alleviates free fatty acid-induced myocardial cell injury via suppressing Nlrp3 inflammasome activation","volume":"12","author":"Zhang","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.intimp.2025.114088_b0140","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0145","article-title":"A systematic study of Erzhu Erchen decoction against damp-heat internalized type 2 diabetes based on data mining and experimental verification. Traditional Medicine","volume":"9","author":"Wang","year":"2024","journal-title":"Research."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0150","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2283590","article-title":"Clinical and pathological characteristics of diquat poisoning-related acute kidney injury","volume":"45","author":"Xia","year":"2023","journal-title":"Ren. Fail."},{"key":"10.1016\/j.intimp.2025.114088_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9841-8_1","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Sagoo","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2025.114088_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114088_b0165","doi-asserted-by":"crossref","first-page":"C1068","DOI":"10.1152\/ajpcell.00425.2021","article-title":"Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies","volume":"322","author":"Nunes","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114088_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: an update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.intimp.2025.114088_b0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/WCO.0000000000000479","article-title":"Diabetic myopathy: current molecular understanding of this novel neuromuscular disorder","volume":"30","author":"Monaco","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114088_b0180","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"issue":"20","key":"10.1016\/j.intimp.2025.114088_b0185","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1007\/s00018-015-1954-7","article-title":"Differential control of muscle mass in type 1 and type 2 diabetes mellitus","volume":"72","author":"Sala","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0190","doi-asserted-by":"crossref","first-page":"e3100","DOI":"10.1002\/dmrr.3100","article-title":"Diabetes pharmacotherapy and effects on the musculoskeletal system","volume":"35","author":"Kalaitzoglou","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.114088_b0195","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","article-title":"Dapagliflozin: A review in type 2 diabetes","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/dom.14582","article-title":"A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide","volume":"24","author":"Tham","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2025.114088_b0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/jdi.13179","article-title":"Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial","volume":"11","author":"Yamakage","year":"2020","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.intimp.2025.114088_b0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cells8070680","article-title":"Mitochondria in health and disease","volume":"8","author":"Annesley","year":"2019","journal-title":"Cells."},{"issue":"2","key":"10.1016\/j.intimp.2025.114088_b0215","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5072","article-title":"Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2 cells","volume":"49","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114088_b0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.26599\/1671-5411.2023.05.003","article-title":"Identification of an LDLR variant in a Chinese familial hypercholesterolemia and its relation to ROS\/NLRP3-Mediated pyroptosis in hepatic cells","volume":"20","author":"Cheng","year":"2023","journal-title":"J Geriatr Cardiol. May 28"},{"key":"10.1016\/j.intimp.2025.114088_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111785","article-title":"Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p\/HO-1\/NLRP3 axis modulation","volume":"131","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114088_b0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/SHK.0000000000002430","article-title":"Gsdmd knockout alleviates sepsis-associated skeletal muscle atrophy by inhibiting Il18\/Ampk signaling","volume":"62","author":"Zhang","year":"2024","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.intimp.2025.114088_b0235","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1159\/000533926","article-title":"Irisin ameliorated skeletal muscle atrophy by inhibiting fatty acid oxidation and pyroptosis induced by palmitic acid in chronic kidney disease","volume":"48","author":"Zhou","year":"2023","journal-title":"Kidney Blood Press. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114088_b0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41581-022-00662-0","article-title":"Gasdermins and pyroptosis in the kidney","volume":"19","author":"Elias","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2025.114088_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176148","article-title":"Mesenchymal stem cells ameliorate H9N2-induced acute lung injury by inhibiting caspase-3-GSDME-mediated pyroptosis of lung alveolar epithelial cells","volume":"960","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114088_b0250","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41401-023-01060-3","article-title":"Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX\/GSDME pathway","volume":"44","author":"Liang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.intimp.2025.114088_b0255","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41419-023-06382-y","article-title":"The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114088_b0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:59:08Z","timestamp":1740617948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S1567576925000773"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114088","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114088"}}